Amerisource Health Recalls Prazosin Capsules Due to Carcinogenic Impurity Risk
Amerisource Health recalls 5mg Prazosin capsules with N-nitroso impurity above safety limits. This may increase cancer risk. Stop using and contact for return.
Stop using this now
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
Contact the company
What happened, in plain English
Amerisource Health is recalling 5mg Prazosin capsules that contain a harmful impurity linked to cancer risk. This affects prescription-only medication sold with specific lot numbers and expiration dates. Read more at govinfonow.com/recall/31690-amerisource-health-recalls-prazosin-capsules-due-to-carcinogenic-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/31690-amerisource-health-recalls-prazosin-capsules-due-to-carcinogenic-impurity-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0103-2026
Cite this page
“Amerisource Health Recalls Prazosin Capsules Due to Carcinogenic Impurity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31690-amerisource-health-recalls-prazosin-capsules-due-to-carcinogenic-impurity-risk. Based on FDA recall #D-0103-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0103-2026%22&limit=1).
Why it’s dangerous
The capsules contain N-nitroso Prazosin impurities at levels above the acceptable safety limit. This impurity has been linked to increased cancer risk, making the product potentially harmful when taken as directed.
Who’s affected
Prescription patients who received the recalled Prazosin capsules with lot numbers 1016996, 1018336, 1021220 (expiring 11/30/2025) or 1022421, 1025017 (expiring 08/31/2026). Patients using these capsules for hypertension or other conditions are most at risk.
How to tell if you have this one
Check the carton for NDC 60687-572-32 and lot numbers 1016996, 1018336, 1021220 (expiring 11/30/2025) or 1022421, 1025017 (expiring 08/31/2026). The product is prescription-only and sold in 20-capsule cartons.
- Brand
Amerisource Health- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
Nationwide within the United States
| Recall number | Product, codes & lots | Quantity | NDC |
|---|---|---|---|
| D-0101-2026 | Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC 68084-996-01. Individual unit dose: NDC 68084-996-11; Lot #: 1023526, 1023555, Expiry: 07/31/2026 | 1,970 cartons | 68084-996-11, 68084-996-01, 68084-997-11, 68084-997-01 |
| D-0102-2026 | Prazosin Hydrochloride, Capsules, USP, 2 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC 68084-997-01, Individual unit dose: NDC 68084-997-11; Lot #: 1020109, Exp. Date 02/28/2026; 1024343, 1025355, Exp. Date 09/30/2026. | 1,818 cartons | 68084-996-11, 68084-996-01, 68084-997-11, 68084-997-01 |
| D-0103-2026 | Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, carton NDC 60687-572-32, Individual unit dose: NDC 60687-572-33; Lot #: 1016996, 1018336, 1021220, Exp. Date 11/30/2025; 1022421, 1025017, Exp. Date 08/31/2026. | 3,410 cartons | 60687-572-33, 60687-572-32 |
What to do — step by step
Stop Using Now
Immediately stop taking the recalled Prazosin capsules and do not use them.
Contact for Return
Contact Amerisource Health directly to arrange a safe return of the product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 20 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Amerisource Health recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0103-2026 (October 16, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0103-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.